. The deconvolution filter must be measured for each subject using a shortstimulus paradigm. It is concluded that deconvolution may be effective in diminishing the hemodynamically imposed temporal blurring and may have potential applications in quantitating responses in eventrelated fMRI.

biophysically plausible framework for explaining different aspects of hemodynamic responses. It also plays an important role in the hemodynamic forward model for dynamic causal modeling (DCM) of fMRI data. A recent study by Obata et al. [Obata, T., Liu, T.T., Miller, K.L., Luh, W.M., Wong, E.C., Frank, L

Mathematical models of cerebral hemodynamics, applicable to humans and rats have been developed and analysed with the purpose of reaching a deeper insight to which degree experimental results on rats can be extrapolated to humans and to clinical management of patients. These models include

–Stokes equations, hemodynamics applications, dimensional splitting preconditioner,

of the computational tools. Assimilation of measured data and numerical models is well established in meteorology, whilst it is relatively new in computational hemodynamics. Different approaches are possible for the mathematical setting of this problem. Among them, we follow here a variational formulation, based

meanings. Functional hemodynamic monitoring implies a therapeutic application, independent of diagnosis such as a therapeutic trial of fluid challenge to assess preload responsiveness. Newer methods for assessing preload responsiveness include monitoring changes in central venous pressure during

We present a lattice Boltzmann (LB) model for the simulation of hemodynamic °ows in the presence of compliant walls. The new scheme is based on the use of a continuous bounce-back boundary condition, as combined with a dynamic constitutive relation between the °ow pres-sure at the wall

I would like to thank the many people who helped be during my PhD work, through discussions, collaborations, encouragements... Approximately in the order I met them: Olivier Faugeras, who accompanied me throughout this thesis- I am particularly grateful to his energy and enthusiasm that were very helpful to lead all these projects and collaborations, and encourage me at difficult times, Renaud Keriven, Miklos Santha and Jacques Stern for their help in the first choices at the time of my Master, Jean-Baptiste Poline, Line Garnero, Sylvain Baillet, Anne-Lise Paradis who helped me to learn something about brain imaging, Lars-Kai Hansen gave me a great confidence by inviting me in Copenhaguen, and Daniel Jacobsen was a nice companion during this first collaboration, Lars Hanson, Torben Lund, and everybody at the Hvidøvre Hospital in Copenhaguen, in particular for offering me an fMRI acquisition, Many thanks to Ivo Vanzetta for sharing his monkey with me, and for the nice and fruitful collaboration we had,

www.karger.com/cnd This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.

IN THE past 10 years many new drugs that lower blood pressure have been introduced for the treatment of hypertension. Several of them have not withstood the rigors of con-trolled clinical trials; others have faded away because side effects precluded their successful application. The useful